Montefiore Einstein Center for Heart and Vascular Care

Medicine & Life Sciences

1. Heart-Assist Devices 100%
2. Extracorporeal Membrane Oxygenation 35%
3. Survival 35%
4. Heart Transplantation 32%
5. Transplants 30%
6. Coronary Artery Bypass 29%
7. Heart 29%
8. Mortality 27%
9. Equipment and Supplies 26%
10. Non-Small Cell Lung Carcinoma 25%
11. Blood Vessels 24%
12. Heart Failure 23%
13. Stroke 21%
14. Mitral Valve 21%
15. Registries 18%
16. Therapeutics 18%
17. Tissue Donors 18%
18. Tricuspid Valve Insufficiency 18%
19. Thoracic Surgery 18%
20. Lung Neoplasms 17%
21. Mitral Valve Insufficiency 16%
22. Surgeons 16%
23. Hemorrhage 15%
24. Thorax 14%
25. Confidence Intervals 14%
26. Transcatheter Aortic Valve Replacement 13%
27. Annual Reports 12%
28. Abdominal Aortic Aneurysm 12%
29. Amputation 12%
30. Renal Dialysis 11%
31. Ischemia 11%
32. Odds Ratio 11%
33. Coronavirus 11%
34. Malpractice 11%
35. Tricuspid Valve 10%
36. Randomized Controlled Trials 9%
37. Extremities 9%
38. Lower Extremity 9%
39. Stem Cells 9%
40. Databases 9%
41. Erythrocyte Transfusion 8%
42. Catheters 8%
43. Dissecting Aneurysm 8%
44. Left Ventricular Dysfunction 8%
45. Primary Graft Dysfunction 8%
46. Transplant Recipients 8%
47. Jurisprudence 8%
48. Multicenter Studies 8%
49. Cardiopulmonary Bypass 8%
50. Aortic Valve 8%
51. Neoplasms 7%
52. Arteriovenous Fistula 7%
53. Costs and Cost Analysis 7%
54. Pediatrics 7%
55. Thrombosis 7%
56. Incidence 7%
57. Transplantation 7%
58. Cardiomyopathies 7%
59. Propensity Score 6%
60. Neoadjuvant Therapy 6%
61. Technology 6%
62. Hemolysis 6%
63. Atrial Fibrillation 6%
64. Coronary Artery Disease 6%
65. Systematic Reviews 6%
66. Aneurysm 6%
67. Hospitalization 6%
68. Clinical Trials 6%
69. Infections 6%
70. Chemoradiotherapy 6%
71. Blood Pressure 6%
72. Cost-Benefit Analysis 6%
73. Lung 6%
74. Stents 6%
75. Hepatitis C Antibodies 5%
76. Child 5%
77. Hematocrit 5%
78. Population 5%
79. Length of Stay 5%
80. Arteries 5%
81. Pandemics 5%
82. Angiodysplasia 5%
83. Cardiac Myocytes 5%
84. Carotid Endarterectomy 5%
85. Cardiogenic Shock 5%
86. Morbidity 5%
87. Pathology 5%
88. Purinergic P2X7 Receptors 5%
89. bivalirudin 5%
90. Stomach Neoplasms 5%
91. Hepatitis C 5%
92. Demography 5%
93. Arterial Occlusive Diseases 5%